This website is intended for healthcare professionals

Safety

Using the British National Formulary app to support safe prescribing: a practical guide

The app can be downloaded from the Apple App Store for iOS devices and the Google Play Store for Android devices (BNF Publications, 2022a)..

Natalizumab for the treatment of highly active MS: risks and benefits

Natalizumab is a DMT that is used in highly active RRMS, which has a high efficacy of 70% for reducing relapses and sustaining disease progression. It is given by intravenous infusion every 4 weeks,...

Why choose Journal of Prescribing Practice?

Journal of Prescribing Practice shares the latest clinical expertise and professional guidance for non-medical prescribers. Our goal is to provide the knowledge to help you prescribe more efficiently and effectively.

What's included

  • Evidence-based best practice

  • Drug updates

  • Pharmacology information

  • Calculation skills

Subscriptions start:

From £16.25 GBP